Case stories

Case stories from our customers.

• A turnkey cleanroom project for the pioneering company Orexo

  Orexo is a specialty pharmaceutical company, focusing on development of new, patented drugs by combining well-documented substances with innovative technologies, and the development of the new treatments for respiratory and inflammatory diseases.

• Award-winning biotech facility

  This ambitious Novo Nordisk project resulted in one of the largest biotech facilities and most advanced part 11-compliant automation systems in the world.

• Building Malaysia’s first GMP-compliant biotech production facility

  In 2005, Inno Biologics set out to build Malaysia’s first GMP-compliant biotech facility. Now completed, the facility has taken Inno Biologics to the forefront of the country’s biotech sector.

• Conceptual design for new Korean biotech facility

  NNE Pharmaplan’s expertise in process technology for patient-specific cell-therapeutics and GMP compliance was needed when a customer had to set up a new production facility in South Korea.

• Coordination of qualification and validation support for a new vaccine facility

  When GlaxoSmithKline Biologicals needed to build a new production facility, it turned to NNE Pharmaplan for qualification and validation support. The facility was finished on schedule and in time to meet seasonal production demands.

• Cross-national project team delivers high-potent API production facility

  Pharmaceutical company Synthon needed a new facility for the production of high-potent active pharmaceutical ingredients (APIs) by chemical synthesis. The company chose NNE Pharmaplan to design and construct this facility.

• Customised disposable solution for production of gene-based products

  Ark Therapeutics Oy needed a BSL2 cell-culture manufacturing plant based on disposable process technology and they had a short time-line to realise it, so they turned to NNE Pharmaplan for the solution.

• Dedicated team delivers validated facility

  Beijing Fresenius Pharmaceutical needed an experienced partner to establish a new validated production facility with European equipment. NNE Pharmaplan did exactly that – and also stayed on site until production was running with full GMP compliance.

• Facility of the Year Award 2005 goes to groundbreaking plant

  The NovoSeven® facility is a state-of-the-art, customised modular plant, designed and engineered by NNE Pharmaplan. Praised for its innovative design, flexibility and execution timeframe, the plant is essential in the production of haemophilia medicine.

• High-containment facility in China with numerous production possibilities

  In 2005, Chinese company Hisun decided to build a new production facility for sterile and non-sterile dosage forms under high-containment conditions. The facility had to be fully cGMP- compliant and be able to produce a range of products.

• Holistic approach to process analysis boosts productivity of sterile production line

  When Fresenius Kabi Austria needed to increase the productivity and output of an existing production line, it looked for a technical consultant that shared its comprehensive take on problem solving.

• Juggling an international team to revamp production facility

  Fresenius Hemocare CZ needed to revamp its existing production facility for blood bags. The company chose NNE Pharmaplan for compliance expertise, and received an added bonus of outstanding team management.

• Long-term relationship supports an infusion solution facility

  Widatra Bhakti was running into capacity problems at its infusion solution facility. Based on its long-term relationship with NNE Pharmaplan, the company got the facility extension it needed while meeting the demands of new authority requirement.

• Meeting tight shutdown deadlines for qualification

  Every year, CSL Behring races against a tight schedule to complete qualification activities during the summer shutdown. Assisting with the qualification work, NNE Pharmaplan helps to make sure that production restarts right on time, every time.

• New Novo Nordisk facility in China

  NNE Pharmaplan helps Novo Nordisk build the world's biggest and most efficient diabetes medication production facility.

• New production facility for biomaterials under GMP conditions

  In 2004, the renowned company Geistlich Pharma in Wolhusen, Switzerland was faced with a substantial surge in demand for their biomaterials (“Bio-Oss”) used as bone implant in surgical operations.

• NNE Pharmaplan contributed to operational excellence

  In 2009, hameln pharma’s sterile production plant designed by NNE Pharmaplan was awarded the prestigious international ISPE Facility of the Year Award in the operational excellence category.

• Pharmaceutical plant built in new record time

  Novo Nordisk is a healthcare company known for quality and innovation. So when the company had to expand its production capacity for a new insulin analogue, new suggestions were welcome – as long as the end result met its high expectations.

• Two-stage flow system improves quality control

  Novo Nordisk wanted to reduce transition time for the release of packing material by implementing a flow system. With a two-stage solution, the company has cut transition time from up to eight days to just one day.